Results 331 to 340 of about 164,448 (358)
Pulmonary Delivery of Inhalable Nanoparticles: Dry Powder Inhalers [PDF]
Therapeutic Delivery, 2011 Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility.
Muhammad Sarfraz +8 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Inhaled Therapies for Pulmonary Hypertension
Respiratory Care, 2015The inhaled route has a number of attractive features for treatment of pulmonary hypertension, including delivery of drug directly to the target organ, thus enhancing pulmonary specificity and reducing systemic adverse effects. It can also improve ventilation/perfusion matching by dilating vessels supplying ventilated regions, thus improving gas ...
Kari E. Roberts +2 more
openaire +3 more sources
Milk antibodies in pulmonary inhalation
Journal of Paediatrics and Child Health, 1983ABSTRACT. To determine the association between inhalation and increased circulating milk antibodies, the presence of milk precipitins and haemagglutinating titres of antibody to casein and lactalbumin were determined in a series of 100 children studied by radionuclide ‘milk scan’and/or barium swallow for possible milk inhalation.
A. S. Kemp +3 more
openaire +3 more sources
Pulmonary effects of marijuana inhalation
Expert Review of Respiratory Medicine, 2011Marijuana is the most commonly used illicit drug around the world. It is most often consumed through smoking, placing the respiratory system in direct contact with the toxic constituents of the drug, which are similar to those of tobacco cigarettes. However, accurate study of the adverse effects of marijuana is difficult to perform, owing to marijuana ...
Matthew T. Naughton, Megan L Howden
openaire +3 more sources
Pulmonary manifestations of inhaled street drugs
Heart & Lung, 1998S ince 1611, when the Jamestown colonists first harvested tobacco, America has witnessed almost 4 centuries of inhalation drug abuse. The first general misuse of tobacco and drugs (opiates) occurred during the 16th century, when these substances were used as a substitute for legal currency.1 Drug scares have come and gone in cycles.
Monroe Karetzky +5 more
openaire +3 more sources
Inhaled Prostanoids in the Therapy of Pulmonary Hypertension
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2008Prostacyclin and prostacyclin analogues are potent vasodilators and possess antithrombotic, anti-inflammatory and antiproliferative properties. These properties qualify them as efficient drugs for the treatment of pulmonary hypertension, a life-threatening illness characterized by an increase in artery pressure and vascular resistance in the pulmonary ...
Werner Seeger +2 more
openaire +3 more sources
Inhalational Drug Delivery in Pulmonary Aspergillosis
Critical Reviews™ in Therapeutic Drug Carrier Systems, 2019Pulmonary infections have long represented one of the major threats to humans. These vary from acute to chronic conditions, depending upon the underlying disease of the airways. Pulmonary aspergillosis (PMAP) has raised vital concerns in the immunocompromised patients.
Ranjot Kaur +6 more
openaire +3 more sources
1995
The toxic effects of inhaling smoke were first documented following the Cleveland Clinic disaster in Ohio on 15 May 1929 and later after the Coconut Grove Nightclub Fire in Boston on 28 November 1942.
openaire +2 more sources
The toxic effects of inhaling smoke were first documented following the Cleveland Clinic disaster in Ohio on 15 May 1929 and later after the Coconut Grove Nightclub Fire in Boston on 28 November 1942.
openaire +2 more sources
Pulmonary oedema associated with hydrocarbon inhalation
Intensive Care Medicine, 1977A patient with gross pulmonary oedema secondary to inhalation of paint fumes is described. Treatment with mechanical ventilation and positive end expiratory pressure was required.
M. Miller, N. Buchanan, R. D. Cane
openaire +3 more sources
Inhalation of Ethyl Alcohol for Pulmonary Edema
New England Journal of Medicine, 1951TREATMENT of experimental pulmonary edema with ethyl alcohol as an antifoaming agent has been described by Luisada.1 However, no clinical experience with this agent has as yet appeared in the liter...
Abraham Gootnick +2 more
openaire +2 more sources